Shitake
Fitoterapia,  Shiitake

Shiitake, beneficios y efectos secundarios

El Shiitake es un hongo. El extracto de este hongo se utiliza como medicamento.

Se le conoce también por otros nombres: Champignon Noir, Champignon Parfumé, Champignon Shiitake, Champignons Shiitake, Forest Mushroom, Hongos Shiitake, Hua Gu, Lenticus edodes, Lentin, Lentin des Chênes, Lentin du Chêne, Lentinan edodes, Lentinula, Lentinula edodes, Lentinus edodes, Mushroom, Pasania Fungus, Shitake, Shiitake, Snake Butter, Tricholomopsis edodes.

Beneficios del hongo Shiitake

Las setas Shiitake se utilizan para estimular el sistema inmune, la reducción de los niveles colesterol en sangre , el tratamiento de cáncer de próstata, y como un agente antienvejecimiento.

Es un alimento que contiene sustancias químicas que podrían ayudar a bajar los niveles de colesterol. Además, aporta cantidades muy pequeñas de una sustancia química que ayuda a evitar el crecimiento de los tumores.

Cancer de próstata. El extracto de hongo Shiitake no parece detener el avance del cáncer de próstata, al menos de acuerdo a una prueba de laboratorio que mide los niveles de antígeno (PSA) específico de la próstata. Los niveles de PSA pueden ser utilizados para medir el progreso de cáncer de próstata.

Cabe señalar que se necesitan más estudios para poder evaluar la eficacia de hongo shiitake para estos usos.

Efectos secundarios del Shiitake

El shiitake en formato medicinal puede causar malestar estomacal, anormalidades en la sangre, la piel y la hinchazón (inflamación). También podría causar un aumento de la sensibilidad al sol, las reacciones alérgicas de la piel y problemas respiratorios.

De cara a las mujeres embarazadas o en período de lactancia, no hay suficiente información fiable acerca de la seguridad de tomar setas shiitake, por lo que debes evitar su uso por seguridad.

Por otra parte, respecto a las enfermedades autoinmunes, como esclerosis múltiple (EM), lupus (lupus eritematoso sistémico, LES), artritis reumatoide (AR) u otras condiciones, el hongo Shiitake podría provocar que el sistema inmunológico se volviese más activo. Esto podría aumentar los síntomas de enfermedades autoinmunes. Si tienes alguna de estas enfermedades, lo mejor es evitar el uso de la seta mencionada.

Por último, si padeces un trastorno de la sangre llamado eosinofilia, no se recomienda tomar el hongo shiitake, ya que podría empeorar la situación.

Dosis de hongos shiitake

La dosis apropiada de hongo shiitake depende de varios factores tales como la edad de la persona, la salud, y varias otras condiciones. En este momento no hay suficiente información científica para determinar un rango de dosis apropiada de hongo shiitake . Ten en cuenta que los productos naturales no son siempre necesariamente seguros y las dosis pueden ser importantes. Asegúrese de seguir las instrucciones en las etiquetas del producto y consulte a su farmacéutico o médico u otro profesional de la salud antes de usarlo.

Referencias

Abrams, D., Greco, M., Wong, R., Goosby, E., Gorter, R., Gordon, M., Guralnik, M., and Kaneko, Y. Results of a phase I/II placebo-controlled dose finding pilot study of lentinan in patients with HIV infection. Int Conf AIDS 1990;6:207.

Arinaga, S., Karimine, N., Takamuku, K., Nanbara, S., Nagamatsu, M., Ueo, H., and Akiyoshi, T. Enhanced production of interleukin 1 and tumor necrosis factor by peripheral monocytes after lentinan administration in patients with gastric carcinoma. Int.J.Immunopharmacol. 1992;14(1):43-47. View abstract.

Chihara, G., Hamuro, J., Maeda, Y., Arai, Y., and Fukuoka, F. Fractionation and purification of the polysaccharides with marked antitumor activity, especially lentinan, from Lentinus edodes (Berk.) Sing. (an edible mushroom). Cancer Res 1970;30(11):2776-2781. View abstract.

Fujiwara, K., Sato, T., Yonei, T., Genba, K., Nogami, N., and Yamadori, I. [A case of chronic hypersensitivity pneumonitis induced by shiitake mushroom spores]. Nihon Kokyuki.Gakkai Zasshi 2000;38(12):908-913. View abstract.

Haas, N., Vogt, R., and Sterry, W. [Shiitake dermatitis: flagellate dermatitis after eating mushrooms]. Hautarzt 2001;52(2):132-135. View abstract.

Hamano, K., Gohra, H., Katoh, T., Fujimura, Y., Zempo, N., and Esato, K. The preoperative administration of lentinan ameliorated the impairment of natural killer activity after cardiopulmonary bypass. Int.J.Immunopharmacol. 1999;21(8):531-540. View abstract.

Hatvani, N. Antibacterial effect of the culture fluid of Lentinus edodes mycelium grown in submerged liquid culture. Int.J.Antimicrob.Agents 2001;17(1):71-74. View abstract.

Ishibashi, H., Hirakawa, K., Nakajima, H., Ioka, J., Shirono, K., Tanabe, S., Ochiai, K., Tomita, K., and Kitagawa, Y. [A case of gastric cancer with peritonitis carcinomatosa which improved upon oral administration of UFT, mitomycin C and lentinan]. Gan To Kagaku Ryoho 1987;14(9):2787-2791. View abstract.

Jones, K. Shiitake: A Major Medicinal Mushroom. Alternative and Complementary Therapies 1998;4(1):53-59.

Kosaka, A., Wani, T., Hattori, Y., and Yamashita, A. [Effect of lentinan administration of adrenalectomized rats and patients with breast cancer]. Gan To Kagaku Ryoho 1982;9(8):1474-1481. View abstract.

Kunitomo, K., Kawahito, M., Miura, M., and Komi, N. [Combination therapy with lentinan, mitomycin c, 5-fluorouracil and radiation–a case of long-term survival of pancreas cancer after palliative surgery]. Gan To Kagaku Ryoho 1987;14(5 Pt 1):1342-1344. View abstract.

Li, J. F., Guo, J. W., and Huang, X. F. [Study on the enhancing effect of polyporus polysaccharide, mycobacterium polysaccharide and lentinan on lymphokine-activated killer cell activity in vitro]. Zhongguo Zhong.Xi.Yi.Jie.He.Za Zhi. 1996;16(4):224-226. View abstract.

Lippert, U., Martin, V., Schwertfeger, C., Junghans, V., Ellinghaus, B., and Fuchs, T. Shiitake dermatitis. Br.J Dermatol. 2003;148(1):178-179. View abstract.

Mio, H. and Terabe, K. [Clinical effects of postoperative immunochemotherapy with a combination of 5-FU, CDDP and lentinan for stage IVb gastric carcinoma and long-term pharmacokinetic studies on CDDP and 5-FU]. Gan To Kagaku Ryoho 1997;24(3):337-342. View abstract.

Mio, H. and Terabe, K. [Postoperative immunochemotherapy for gastric carcinoma with peritoneal dissemination–the effects with the combination of CDDP, 5-FU and lentinan]. Gan To Kagaku Ryoho 1994;21(4):531-534. View abstract.

Miyakoshi, H. and Aoki, T. Acting mechanisms of Lentinan in human–I. Augmentation of DNA synthesis and immunoglobulin production of peripheral mononuclear cells. Int.J.Immunopharmacol. 1984;6(4):365-371. View abstract.

Nakamura, T. and Kobayashi, A. [Toxicodermia cause by the edible mushroom shiitake (Lentinus edodes)]. Hautarzt 1985;36(10):591-593. View abstract.

Nakayama, H., Aoki, N., Hayashi, S., Wakabayashi, K., Karube, H., Ogame, H., Aoki, H., Sakamoto, N., Masuda, H., and Hemmi, A. [A case of long survival with UFT and lentinan treatment in a patient with peritoneal metastasis of gastric carcinoma]. Gan To Kagaku Ryoho 2004;31(2):241-243. View abstract.

Nanba, H., Mori, K., Toyomasu, T., and Kuroda, H. Antitumor action of shiitake (Lentinus edodes) fruit bodies orally administered to mice. Chem Pharm Bull.(Tokyo) 1987;35(6):2453-2458. View abstract.

Nimura, H., Mitsumori, N., Takahashi, N., Kashimura, H., Takayama, S., Kashiwagi, H., and Yanaga, K. [S-1 combined with lentinan in patients with unresectable or recurrent gastric cancer]. Gan To Kagaku Ryoho 2006;33 Suppl 1:106-109. View abstract.

Oka, M., Hazama, S., Suzuki, M., Wang, F., Wadamori, K., Iizuka, N., Takeda, S., Akitomi, Y., Ohba, Y., Kajiwara, K., Suga, T., and Suzuki, T. In vitro and in vivo analysis of human leukocyte binding by the antitumor polysaccharide, lentinan. Int.J.Immunopharmacol. 1996;18(3):211-216. View abstract.

Peter, G., Karoly, V., Imre, B., Janos, F., and Kaneko, Y. Effects of lentinan on cytotoxic functions of human lymphocytes. Immunopharmacol.Immunotoxicol. 1988;10(2):157-163. View abstract.

Sakamaki, S., Kohgo, Y., Suzuki, M., Ogiwara, R., Suga, T., Kondo, N., Izawa, M., Kanisawa, Y., and Niitsu, Y. Individual diversity of IL-6 generation by human monocytes with lentinan administration. Int.J.Immunopharmacol. 1993;15(6):751-756. View abstract.

Sano, T., Nomura, K., Adachi, M., and Kobori, O. [An advanced gastric carcinoma which responded to combined administration of mitomycin C, FT-207, and lentinan immunochemotherapy]. Gan No Rinsho 1990;36(1):97-100. View abstract.

Sastre, J., Ibanez, M. D., Lopez, M., and Lehrer, S. B. Respiratory and immunological reactions among Shiitake (Lentinus edodes) mushroom workers. Clin.Exp.Allergy 1990;20(1):13-19. View abstract.

Sugiyama, K., Akachi, T., and Yamakawa, A. Hypocholesterolemic action of eritadenine is mediated by a modification of hepatic phospholipid metabolism in rats. J Nutr 1995;125(8):2134-2144. View abstract.

Suzuki, H., Iiyama, K., Yoshida, O., Yamazaki, S., Yamamoto, N., and Toda, S. Structural characterization of the immunoactive and antiviral water-solubilized lignin in an extract of the culture medium of Lentinus edodes mycelia (LEM). Agric.Biol Chem 1990;54(2):479-487. View abstract.

Taguchi, T. [Effects of lentinan in advanced or recurrent cases of gastric, colorectal, and breast cancer]. Gan To Kagaku Ryoho 1983;10(2 Pt 2):387-393. View abstract.

Takashima, K., Sato, C., Sasaki, Y., Morita, T., and Takeyama, S. Effect of eritadenine on cholesterol metabolism in the rat. Biochem Pharmacol 1-15-1974;23(2):433-438. View abstract.

Takemura, T., Takahashi, S., Yoshikawa, T., and Kondo, M. [A case of advanced gastric cancer (type 3) with pyloric stenosis, multiple liver and lymph node metastases responding to UFT-E granules and lentinan]. Gan To Kagaku Ryoho 2000;27(1):107-111. View abstract.

Takeshita, K., Hayashi, S., Tani, M., Kando, F., Saito, N., and Endo, M. Monocyte function associated with intermittent lentinan therapy after resection of gastric cancer. Surg.Oncol. 1996;5(1):23-28. View abstract.

Tochikura, T. S., Nakashima, H., Ohashi, Y., and Yamamoto, N. Inhibition (in vitro) of replication and of the cytopathic effect of human immunodeficiency virus by an extract of the culture medium of Lentinus edodes mycelia. Med.Microbiol.Immunol.(Berl) 1988;177(5):235-244. View abstract.

Van Loon, P. C., Cox, A. L., Wuisman, O. P., Burgers, S. L., and Van Griensven, L. J. Mushroom worker’s lung. Detection of antibodies against Shii-take (Lentinus edodes) spore antigens in Shii-take workers. J.Occup.Med. 1992;34(11):1097-1101. View abstract.

Wakui, A., Kasai, M., Konno, K., Abe, R., Kanamaru, R., Takahashi, K., Nakai, Y., Yoshida, Y., Koie, H., Masuda, H., and . [Randomized study of lentinan on patients with advanced gastric and colorectal cancer. Tohoku Lentinan Study Group]. Gan To Kagaku Ryoho 1986;13(4 Pt 1):1050-1059. View abstract.

Wong, G. Y. C., Katdarae, M., Osborne, M. P., and Telang, N. T. Preventative efficacy of Lentinus edodes mycelium extract (LEM) in human mammary carcinogenesis (abstract 321). 19th Annual San Antonio Breast Cancer Symposium, (San Antonio, Texas) 1996;265.

Yajima, Y., Satoh, J., Fukuda, I., Kikuchi, T., and Toyota, T. Quantitative assay of lentinan in human blood with the limulus colorimetric test. Tohoku J.Exp.Med. 1989;157(2):145-151. View abstract.

Yamamoto, Y., Shirono, H., Kono, K., and Ohashi, Y. Immunopotentiating activity of the water-soluble lignin rich fraction prepared from LEM–the extract of the solid culture medium of Lentinus edodes mycelia. Biosci.Biotechnol.Biochem. 1997;61(11):1909-1912. View abstract.

Yang, P., Liang, M., Zhang, Y., and Shen, B. Clinical application of a combination therapy of lentinan, multi-electrode RFA and TACE in HCC. Adv.Ther 2008;25(8):787-794. View abstract.

Yin, G., Yu, J., and Li, D. [Immune modulatory and therapeutic effect of lentinan on condyloma acuminatum]. Zhongguo Zhong.Xi.Yi.Jie.He.Za Zhi. 1998;18(11):665-667. View abstract.

Yoshino, S., Tabata, T., Hazama, S., Iizuka, N., Yamamoto, K., Hirayama, M., Tangoku, A., and Oka, M. Immunoregulatory effects of the antitumor polysaccharide lentinan on Th1/Th2 balance in patients with digestive cancers. Anticancer Res. 2000;20(6C):4707-4711. View abstract.

Arinaga S, Karimine N, Takamuku K, et al. Enhanced induction of lymphokine-activated killer activity after lentinan administration in patients with gastric carcinoma. Int J Immunopharmac 1992;14:535-539. View abstract.

Hanada K, Hashimoto I. Flagellate mushroom (Shiitake) dermatitis and photosensitivity. Dermatol 1998;197:255-7. View abstract.

Hitosugi M, Kitamura O, Takatsu A, Yoshino Y. Autopsy case of duodenal obstruction from impacted mushroom. J Gastroenterol 1998;33:562-5. View abstract.

Kim HS, Kacew S, Lee BM. In vitro chemopreventive effects of plant polysaccharides (Aloe barbadensis miller, Lentinus edodes, Ganoderma lucidum and Coriolus versicolor). Carcinogenesis 1999;20:1637-40. View abstract.

Kosaka A, Kuzuoka M, Yamafuji K, et al. [Synergistic action of lentinan (LNT) with endocrine therapy of breast cancer in rats and humans]. Gan To Kagaku Ryoho 1987;14:516-22. View abstract.

Levy AM, Kita H, Phillips SF, et al. Eosinophilia and gastrointestinal symptoms after ingestion of shiitake mushrooms. J Allergy Clin Immunol 1998;101:613-20. View abstract.

Matsui S, Nakazawa T, Umegae Y, Mori M. Hypersensitivity pneumonitis induced by Shiitake mushroom spores. Intern Med 1992;31:1204-6. View abstract.

Matsuoka H, Seo Y, Wakasugi H, et al. Lentinan potentiates immunity and prolongs the survival time of some patients. Anticancer Res 1997;17:2751-5. View abstract.

Murakami M, Kawabe K, Hosoi Y, et al. Decreased pulmonary perfusion in hypersensitivity pneumonitis caused by Shiitake mushroom spores. J Intern Med 1997;241:85-8. View abstract.

Nakamura T. Shiitake (Lentinus edodes) dermatitis. Contact Dermatitis 1992;27:65-70. View abstract.

Nishihira T, Akimoto M, Mori S. [Anti-cancer effects of BRMs associated with nutrition in cancer patients]. Gan To Kagaku Ryoho,1988;15:1615-20. View abstract.

Otsuka M, Shinozuka K, Hirata G, Kunitomo M. [Influences of a shiitake (Lentinus edodes)-fructo-oligosaccharide mixture (SK-204) on experimental pulmonary thrombosis in rats]. Yakugaku Zasshi 1996;116:169-73. View abstract.

Taguchi T. Clinical efficacy of lentinan on patients with stomach cancer: end point results of a four-year follow-up survey. Cancer Detect Prev Suppl 1987;1:333-49. View abstract.

Wada T, Nishide T, Hatayama K, et al. [A comparative clinical trial with tegafur plus lentinan treatment at two different doses in advanced cancer]. Gan To Kagaku Ryoho 1987;14:2509-11. View abstract.

Yoshiyuki T, Onda M, Tokunaga A, et al. [Treatment for peritoneal dissemination of gastric cancer by intraperitoneal administration of CDDP through Infuse-a-Port]. Gan To Kagaku Ryoho 1994;21:2323-5. View abstract.

Para una vida más saludable! Sigue nuestros consejos de bienestar, medicina tradicional y nutrición saludable.

Dinos que te pareció

Este sitio usa Akismet para reducir el spam. Aprende cómo se procesan los datos de tus comentarios.